Sitagliptin & Metformin Hydrochloride (Extended Release) Tablets

Composition: Each tablet contains:

• Sitagliptin Phosphate Monohydrate equivalent to Sitagliptin – 100 mg

• Metformin Hydrochloride (ER) – 1000 mg

Dosage Form: Tablet (Extended Release)
Route of Administration: Oral

Drug Class:

• Sitagliptin – DPP-4 Inhibitor (Dipeptidyl Peptidase-4 inhibitor)

• Metformin – Biguanide (Antihyperglycemic agent)

Therapeutic Use:
Used to improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise, by enhancing insulin secretion, reducing hepatic glucose production, and improving insulin sensitivity.